
| ASSET | DATE | % RETURN |
|---|---|---|
Shattuck Labs (STTK) | 12/5/2023 - 12/15/2023 | 238.45% |
C4 Therapeutics (CCCC) | 12/5/2023 - 12/15/2023 | 223.53% |
Global Interactive Technologies (GITS) | 12/5/2023 - 12/15/2023 | 206.33% |
Sera Prognostics (SERA) | 12/5/2023 - 12/15/2023 | 145.61% |
JetAI (JTAI) | 12/5/2023 - 12/15/2023 | 139.33% |
Intensity Therapeutics, Inc Common stock (INTS) | 12/5/2023 - 12/15/2023 | 124.51% |
In8bio (INAB) | 12/5/2023 - 12/15/2023 | 117.54% |
TriSalus Life Sciences (TLSI) | 12/5/2023 - 12/15/2023 | 113.92% |
Conduit Pharmaceuticals (CDT) | 12/5/2023 - 12/15/2023 | 101.71% |
LQR House (YHC) | 12/5/2023 - 12/15/2023 | 97.69% |
Zivo Bioscience (ZIVO) | 12/5/2023 - 12/15/2023 | 96.64% |
MBIA (MBI) | 12/5/2023 - 12/15/2023 | 85.21% |
Battalion Oil (BATL) | 12/5/2023 - 12/15/2023 | 84.78% |
Lixiang Education (LXEH) | 12/5/2023 - 12/15/2023 | 81.79% |
Century Therapeutics (IPSC) | 12/5/2023 - 12/15/2023 | 79.63% |
Gaotu Techedu Inc DRC (GOTU) | 12/5/2023 - 12/15/2023 | 76.05% |
Bitfarms (BITF) | 12/5/2023 - 12/15/2023 | 68.75% |
Altimmune (ALT) | 12/5/2023 - 12/15/2023 | 68.57% |
Marker Therapeutics (MRKR) | 12/5/2023 - 12/15/2023 | 67.86% |
Alx Oncology Holdings (ALXO) | 12/5/2023 - 12/15/2023 | 67.08% |
Cardio Diagnostics (CDIO) | 12/5/2023 - 12/15/2023 | 63.64% |
Monte Rosa Therapeutics (GLUE) | 12/5/2023 - 12/15/2023 | 62.87% |
Bt Brands (BTBD) | 12/5/2023 - 12/15/2023 | 60.13% |
Solid Biosciences LLC (SLDB) | 12/5/2023 - 12/15/2023 | 56.8% |
Aurora Innovation (AUR) | 12/5/2023 - 12/15/2023 | 55.92% |